Amazon Bio Discovery's three AI methods accelerate antibody drug design
Original titleAmazon Bio Discovery developed three AI approaches to accelerate antibody drug design: MochiBind (sequence-based affinity ranking), CA-MA...
AISummary
Amazon Bio Discovery developed three AI approaches for antibody drug design: MochiBind for sequence-based affinity ranking, CA-MAP for developability prediction with batch effect correction, and an agent-guided design system. The agent-guided system produced 46 lab-validated hits against a novel cancer target.
Source: Amazon Science · x.comPublished · added here